A S Lascaux, P Lesprit, M Bertocchi, Y Levy. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAnti-HIV Agents/adverse effectsAnti-HIV Agents/therapeutic useAntiretroviral Therapy, Highly Active/adverse effectsEdema/chemically inducedFemaleHIV Infections/drug therapyHIV Protease Inhibitors/adverse effectsHIV Protease Inhibitors/therapeutic useHumansInflammation/chemically inducedLeg/pathologyLopinavirMaleMiddle AgedPyrimidinones/adverse effectsPyrimidinones/therapeutic use
Substances： See more » Anti-HIV AgentsHIV Protease InhibitorsPyrimidinonesLopinavir
Year: 2001 PMID： 11371707 DOI： 10.1097/00002030-200104130-00028
Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177